Pseudoprogression and Pseudoresponse in the Management of High-Grade Glioma : Optimal Decision Timing According to the Response Assessment of the Neuro-Oncology Working Group

OBJECTIVE: We evaluated pseudoprogression (PsPD) following radiation therapy combined with concurrent temozolomide (TMZ), and we assessed pseudoresponse following anti-angiogenic therapy for patients with recurrent disease using the Response Assessment of the Neuro-Oncology Working Group. METHODS: P...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ji Hyun, Kim, Chae-Yong, Choi, Byung Se, Kim, Yu Jung, Kim, Jae Sung, Kim, In Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Neurosurgical Society 2014
Materias:
Clinical Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928350/
https://www.ncbi.nlm.nih.gov/pubmed/24570811
http://dx.doi.org/10.3340/jkns.2014.55.1.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928350/
https://www.ncbi.nlm.nih.gov/pubmed/24570811
http://dx.doi.org/10.3340/jkns.2014.55.1.5

Ejemplares similares